Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
2 |
2 |
NM_139913.1 |
CG13681-RA (CG13681), mRNA |
0.2 |
1 |
2 |
2 |
5 |
NM_136091.3 |
CG10473-RA, transcript variant A (CG10473), mRNA |
0.2 |
1 |
2 |
2 |
3 |
NM_165273.1 |
CG10473-RB, transcript variant B (CG10473), mRNA |
0 |
0 |
4 |
3 |
4 |
NM_167474.1 |
CG8909-RB (CG8909), mRNA |
0 |
0 |
4 |
2 |
4 |
NM_169882.1 |
CG4836-RB, transcript variant B (CG4836), mRNA |
0 |
0 |
4 |
2 |
4 |
NM_169883.1 |
CG4836-RA, transcript variant A (CG4836), mRNA |
0 |
0 |
4 |
2 |
4 |
NM_142599.1 |
CG4836-RC, transcript variant C (CG4836), mRNA |
0 |
0 |
3 |
3 |
13 |
NM_057941.3 |
CG5227-RA, transcript variant A (sdk), mRNA |
0 |
0 |
3 |
3 |
13 |
NM_134314.2 |
CG5227-RB, transcript variant B (sdk), mRNA |
0 |
0 |
3 |
3 |
13 |
NM_134315.2 |
CG5227-RD, transcript variant D (sdk), mRNA |
0 |
0 |
3 |
3 |
13 |
NM_057942.3 |
CG5227-RC, transcript variant C (sdk), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_057882.3 |
CG1609-RA (Gcn2), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_137546.2 |
CG15105-RA, transcript variant A (CG15105), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_166318.1 |
CG15105-RB, transcript variant B (CG15105), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_131951.1 |
CG15473-RA (CG15473), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_137806.2 |
CG5465-RA (MED16), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_078871.4 |
CG10305-RB, transcript variant B (RpS26), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_165252.1 |
CG10305-RA, transcript variant A (RpS26), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_165253.1 |
CG10305-RC, transcript variant C (RpS26), mRNA |
0 |
0 |
1 |
3 |
5 |
NM_143704.1 |
CG2916-RB, transcript variant B (Sep5), mRNA |
0 |
0 |
1 |
3 |
5 |
NM_165578.1 |
CG2916-RA, transcript variant A (Sep5), mRNA |
0 |
0 |
1 |
3 |
4 |
NM_168571.2 |
CG32133-RA (CG32133), mRNA |
0 |
0 |
1 |
3 |
4 |
NM_142367.1 |
CG5866-RA (CG5866), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_079159.2 |
CG1004-RA (rho), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_132068.1 |
CG15899-RB (Ca-alpha1T), mRNA |
0 |
0 |
1 |
2 |
4 |
NM_001038730.1 |
CG3711-RB, transcript variant B (CG3711), mRNA |
0 |
0 |
1 |
2 |
4 |
NM_130513.2 |
CG3711-RA, transcript variant A (CG3711), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_141998.1 |
CG11670-RA (CG11670), mRNA |
0 |
0 |
0 |
7 |
3 |
NM_165497.1 |
CG3358-RA, transcript variant A (CG3358), mRNA |
0 |
0 |
0 |
7 |
3 |
NM_136404.2 |
CG3358-RB, transcript variant B (CG3358), mRNA |
|